Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tc99m-PYP Scintigraphy in Order to Establish Incidence of Cardiac Transthyretin Amyloidosis Among Patients With Otherwise Unexplained Cardiomyopathies

NCT03098901 is registered in ClinicalTrials.gov with Kaplan Medical Center as lead sponsor.

NCT NCT03098901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03098901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tc99m-PYP Scintigraphy in Order to Establish Incidence of Cardiac Transthyretin Amyloidosis Among Patients With Otherwise Unexplained Cardiomyopathies
Lead sponsor
Kaplan Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
April 15, 2017
Completion date
April 15, 2018
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac ttr amyloidosis